OpenVSafe by OpenVAERS
Search V-safe

T3A-10224-07863

2 vaccinations 4 coded responses 8 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
481 / MI
Registered
2021-01-14
Relationship
Self
Race
White
Ethnicity
N/A

Timeline

  1. 2021-01-14
    Registered in v-safe
  2. 2021-01-14
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-14
    Survey response — day 0, dose 1
    MedDRA: Paraesthesia — Feeling: Good · Site: Pain
    Free text: Tingling face
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-04
    Dose 2 — Pfizer-BioNTech
  9. 2021-02-04
    Survey response — day 0, dose 2
    MedDRA: Hypoaesthesia, Paraesthesia — Feeling: Good · Site: Pain
    Free text: Numbness/tingles in face
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-08-05
    Survey response — 6 months, dose 2
    MedDRA: Abortion spontaneous — Feeling: Good
    Free text: Two miscarriages
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  11. 2022-02-04
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Additional miscarriage (4th since shot)
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-02-04
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  13. 2022-02-07
  14. 2022-03-11
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Pfizer-BioNTech
22021-02-04Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-02-04 Successful
2022-03-11
Participant prefers to complete VAERS report online

Free text

Release 2 — day 0, dose 1

2021-01-14

Systemic reaction (other): Tingling face

Release 3 — day 0, dose 2

2021-02-04

Systemic reaction (other): Numbness/tingles in face

Release 9 — 6 months, dose 2

2021-08-05

Symptoms: Two miscarriages

Release 11 — 12 months, dose 2

2022-02-04

Symptoms: Additional miscarriage (4th since shot)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous ✓ · ✓
SROHypoaesthesia ✓ ✓ ✓
SROParaesthesia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release